[PDF] Top 20 Evaluación y análisis de propiedades estructurales de productos de madera
Has 10000 "Evaluación y análisis de propiedades estructurales de productos de madera" found on our website. Below are the top 20 most common "Evaluación y análisis de propiedades estructurales de productos de madera".
Serum erythropoietin levels in patients with central serous chorioretinopathy
... marrow. Erythropoietin has recently been shown to exhibit remarkable antioxidant and antiapoptotic effects on various cell types such as retinal neu- rons and RPE cells, besides its angiogenic activity on vascular ... See full document
5
Subfoveal choroidal thickness after photodynamic therapy in patients with acute idiopathic central serous chorioretinopathy
... with various doses of verteporfin (70%, 60%, 50%, 40%, 30%, 20%, and 10% of the full dose) to manage ICSCR patients, and their results showed that 30% of the full dose of verteporfin was the lowest effective dose. ... See full document
25
The effect of eradicating <em>Helicobacter pylori</em> on idiopathic central serous chorioretinopathy patients
... could benefit BCVA outcomes in chronic ICSCR patients. More research is needed to illuminate the changes in retinal sensitivity after H. pylori eradication in chronic ICSCR patients. In our study, serology ... See full document
187
In patients suffering from idiopathic central serous chorioretinopathy, anxiety scores are higher than in healthy controls, but do not vary according to sex or repeated central serous chorioretinopathy
... both patients and healthy controls involved a brief medical interview and medical analysis of CSCR, focusing on current and past CSCR (for patients only), and on ...assessed. Patients with a first or ... See full document
7
Choroidal thickness in older patients with central serous chorioretinopathy
... The measurement of the choroid was not possible in 5 eyes (29.4 %) with active CSCR and in two inactive con- tralateral eyes (15.4 %). This is likely due to a loss of signal penetration and intensity due to the increased ... See full document
9
Choroidal thickness measurement by enhanced depth imaging and swept-source optical coherence tomography in central serous chorioretinopathy
... measured serous retinal detachment (SRD) only with SS-OCT, from the outer surface of the neurosensory retina and the ...study. Patients who had undergone focal laser photocoagulation were included in the ... See full document
30
Profile of verteporfin and its potential for the treatment of central serous chorioretinopathy
... Ten patients received placebo, consisting of infusion of normal saline instead of verteporfin, followed by laser application in the same manner as the treatment ...0.003). Central foveal thickness decreased ... See full document
6
Microsecond yellow laser for subfoveal leaks in central serous chorioretinopathy
... We evaluated ten eyes of ten male patients with treatment- naïve persistent CSC, with a mean age of 38.2 ± 4.37 years. Average duration of symptoms was 7.2 ± 4.3 months. All ten eyes showed subfoveal leak on FFA ... See full document
21
<p>Treatment of central serous chorioretinopathy with topical NSAIDs</p>
... 27 patients/eyes with CSCR were reviewed, with 14 eyes being treated with topical NSAIDs and 13 eyes ...visit, patients in the control group were skewed toward having no improvement in the subretinal fl uid ... See full document
25
Intravitreal Bevacizumab for the Treatment of Chronic or Recurrent Central Serous Chorioretinopathy
... of serous retinal detachment one month after treatment in 75% of ...these patients generally have better vision compared with those with exudative maculopathy secondary to ... See full document
6
Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy
... determined: central retinal thickness (CRT), central retinal volume (cube volume; CV), average CRT (CRTA), and maximum SRF ...the central circle of the posterior pole measuring 1 mm in diameter, the ... See full document
24
Comparison of efficacy between low-fluence and half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy
... Overall, our study demonstrated that at the last visit, low- fluence and half-dose verteporfin PDT resulted in complete resolution of subretinal fluid in 91.6% and 92.8% of eyes at the last visit, respectively, without ... See full document
8
Efficacy of 1/3 Dose Verteporfin Photodynamic Therapy for Subacute Central Serous Chorioretinopathy
... Central serous chorioretinopathy (CSC) frequently affects young-to-middle-aged men [1] ...the patients experience persistent or recurrent SRF [5] ...these patients, the prognosis can be ... See full document
53
Changes in macular sensitivity after half-dose photodynamic therapy for chronic central serous chorioretinopathy
... Our results demonstrate that macular sensitivity as assessed with ASP can be improved after half-dose ver- teporfin PDT. This is clinically important as visual acu- ity often does not capture the visual disturbances of ... See full document
7
Retinal and choroidal changes in steroid-associated central serous chorioretinopathy
... CSC patients [28], suggesting that the blood flow might be variable in different layers of the ...in patients with acute CSC, “choroidal vascularity index” (CVI), a ratio of luminal area and total choroidal ... See full document
47
Short-term efficacy of intravitreal dobesilate in central serous chorioretinopathy
... Central serous chorioretinopathy (CSC) is a well- characterized self-limiting disorder leading to serous neu- rosensory elevation of the ...many patients resolves spontaneously, with ... See full document
18
Visual Functions after Laser Photocoagulation in Central Serous Chorioretinopathy
... Fourteen patients (14 males) of median age 44 years (range 35 to 51 years) with the first attack of unilateral acu- te idiopathic CSC were treated at the Department of Oph- thalmology of the Charles University in ... See full document
99
Eplerenone in the treatment of central serous chorioretinopathy: a review of the literature
... in patients with CSCR treated with oral ...of patients and short follow-up. On the other hand, patients presenting widespread retinal pigment epithelium changes are less likely to benefit from ... See full document
7
Clinical characteristics and long-term visual outcome of severe phenotypes of chronic central serous chorioretinopathy
... patients in their study had previously experienced an acute CSC episode. Therefore, these observations at least indicate that a well observed, clinical episode of acute CSC is not required to evolve to chronicity ... See full document
20
Oral mineralocorticoid antagonists for recalcitrant central serous chorioretinopathy
... treatment-naïve patients and those previously treated for a prior exacerbation of CSCR (deemed “recalcitrant”) was ...Only patients treated with oral mineralocorticoid antagonists (eplerenone and/or ... See full document
6
Related subjects